Medigene AG
MDGEF · OTC
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $54 | $61 | $88 | $91 |
| - Cash | $14 | $9 | $17 | $22 |
| + Debt | $3 | $2 | $2 | $4 |
| Enterprise Value | $43 | $55 | $74 | $72 |
| Revenue | $4 | $3 | $3 | $6 |
| % Growth | 50.7% | -3.1% | -48.6% | – |
| Gross Profit | $4 | $2 | $2 | $5 |
| % Margin | 82.7% | 75.7% | 69.9% | 80.4% |
| EBITDA | -$6 | -$9 | -$7 | $17 |
| % Margin | -132.6% | -297.8% | -218.7% | 291.5% |
| Net Income | -$7 | -$9 | -$7 | -$22 |
| % Margin | -150.3% | -310% | -227.5% | -373.1% |
| EPS Diluted | -0.52 | -0.37 | -0.28 | -0.91 |
| % Growth | -40.5% | -32.1% | 69.2% | – |
| Operating Cash Flow | -$7 | -$7 | -$8 | -$5 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$7 | -$7 | -$8 | -$6 |